Boston Scientific Comprehensive Income 2010-2024 | BSX
Boston Scientific comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Boston Scientific comprehensive income for the quarter ending September 30, 2024 was $0.164B, a 21.15% decline year-over-year.
- Boston Scientific comprehensive income for 2023 was $0.049B, a 81.78% decline from 2022.
- Boston Scientific comprehensive income for 2022 was $0.269B, a 2.28% increase from 2021.
- Boston Scientific comprehensive income for 2021 was $0.263B, a 27.05% increase from 2020.
| Boston Scientific Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $49 |
| 2022 | $269 |
| 2021 | $263 |
| 2020 | $207 |
| 2019 | $270 |
| 2018 | $33 |
| 2017 | $-59 |
| 2016 | $1 |
| 2015 | $88 |
| 2014 | $144 |
| 2013 | $106 |
| 2012 | $-33 |
| 2011 | $-138 |
| 2010 | $-129 |
| 2009 | $-43 |
| Boston Scientific Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $164 |
| 2024-03-31 | $132 |
| 2023-12-31 | $49 |
| 2023-09-30 | $231 |
| 2023-06-30 | $208 |
| 2023-03-31 | $178 |
| 2022-12-31 | $269 |
| 2022-09-30 | $532 |
| 2022-06-30 | $433 |
| 2022-03-31 | $222 |
| 2021-12-31 | $263 |
| 2021-09-30 | $238 |
| 2021-06-30 | $237 |
| 2021-03-31 | $254 |
| 2020-12-31 | $207 |
| 2020-09-30 | $151 |
| 2020-06-30 | $131 |
| 2020-03-31 | $168 |
| 2019-12-31 | $270 |
| 2019-09-30 | $138 |
| 2019-06-30 | $78 |
| 2019-03-31 | $87 |
| 2018-12-31 | $33 |
| 2018-09-30 | $25 |
| 2018-06-30 | $-16 |
| 2018-03-31 | $-128 |
| 2017-12-31 | $-59 |
| 2017-09-30 | $-51 |
| 2017-06-30 | $-53 |
| 2017-03-31 | $-46 |
| 2016-12-31 | $1 |
| 2016-09-30 | $-99 |
| 2016-06-30 | $-70 |
| 2016-03-31 | $35 |
| 2015-12-31 | $88 |
| 2015-09-30 | $81 |
| 2015-06-30 | $104 |
| 2015-03-31 | $142 |
| 2014-12-31 | $144 |
| 2014-09-30 | $110 |
| 2014-06-30 | $42 |
| 2014-03-31 | $72 |
| 2013-12-31 | $106 |
| 2013-09-30 | $56 |
| 2013-06-30 | $82 |
| 2013-03-31 | $45 |
| 2012-12-31 | $-33 |
| 2012-09-30 | $-112 |
| 2012-06-30 | $-87 |
| 2012-03-31 | $-79 |
| 2011-12-31 | $-138 |
| 2011-09-30 | $-132 |
| 2011-06-30 | $-123 |
| 2011-03-31 | $-119 |
| 2010-12-31 | $-129 |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | $-18 |
| 2009-12-31 | $-43 |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $130.404B | $14.240B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $202.584B | 25.84 |
| Stryker (SYK) | United States | $144.427B | 32.55 |
| Medtronic (MDT) | Ireland | $113.203B | 16.84 |
| EssilorLuxottica (ESLOY) | France | $112.107B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.279B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| GE HealthCare Technologies (GEHC) | United States | $39.012B | 20.24 |
| ResMed (RMD) | United States | $36.507B | 30.00 |
| Terumo (TRUMY) | Japan | $30.649B | 43.28 |
| Koninklijke Philips (PHG) | Netherlands | $24.871B | 19.04 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.791B | 13.87 |
| Insulet (PODD) | United States | $19.339B | 77.01 |
| Baxter (BAX) | United States | $17.458B | 11.37 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.816B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.245B | 34.82 |
| BellRing Brands (BRBR) | United States | $9.218B | 38.97 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.846B | 13.58 |
| TG Therapeutics (TGTX) | United States | $4.785B | 0.00 |
| Haemonetics (HAE) | United States | $4.590B | 22.40 |
| ICU Medical (ICUI) | United States | $4.354B | 41.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.039B | 20.09 |
| Perrigo (PRGO) | Ireland | $3.645B | 10.73 |
| Envista Holdings (NVST) | United States | $3.571B | 26.60 |
| Neogen (NEOG) | United States | $3.554B | 41.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.448B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $3.068B | 19.67 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.891B | 18.61 |
| LeMaitre Vascular (LMAT) | United States | $2.372B | 57.65 |
| Warby Parker (WRBY) | United States | $2.084B | 0.00 |
| AtriCure (ATRC) | United States | $1.862B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.651B | 28.90 |
| InMode (INMD) | Israel | $1.638B | 9.85 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.458B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.405B | 10.05 |
| BioLife Solutions (BLFS) | United States | $1.227B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.079B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 18.25 |
| Owens & Minor (OMI) | United States | $1.031B | 8.05 |
| CeriBell (CBLL) | United States | $0.983B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.931B | 31.10 |
| Capricor Therapeutics (CAPR) | United States | $0.887B | 0.00 |
| Evolus (EOLS) | United States | $0.831B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.598B | 18.04 |
| Quanterix (QTRX) | United States | $0.588B | 0.00 |
| Surmodics (SRDX) | United States | $0.549B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.546B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.508B | 0.00 |
| Valneva SE (VALN) | France | $0.417B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.19 |
| Canopy Growth (CGC) | Canada | $0.379B | 0.00 |
| Cerus (CERS) | United States | $0.377B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.370B | 35.22 |
| OraSure Technologies (OSUR) | United States | $0.316B | 21.20 |
| Biote (BTMD) | United States | $0.312B | 14.38 |
| Sanara MedTech (SMTI) | United States | $0.306B | 0.00 |
| Zynex (ZYXI) | United States | $0.296B | 62.00 |
| MacroGenics (MGNX) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.262B | 0.00 |
| Jin Medical (ZJYL) | China | $0.250B | 0.00 |
| Omeros (OMER) | United States | $0.249B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 16.05 |
| High Tide (HITI) | Canada | $0.213B | 88.33 |
| TerrAscend (TSNDF) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.180B | 216.00 |
| Organigram Holdings (OGI) | Canada | $0.169B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 20.99 |
| Rockwell Medical (RMTI) | United States | $0.144B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.140B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.117B | 0.00 |
| Veru (VERU) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 9.76 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.20 |
| Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.081B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.079B | 2.69 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.066B | 0.00 |
| Safety Shot (SHOT) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| MariMed (MRMD) | United States | $0.055B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.053B | 0.00 |
| Exagen (XGN) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.051B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.047B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 13.60 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |